Blood Coagulation Disorders: Clinical Trials

2,148 trials for Blood Coagulation Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1146 completed, 302 unknown, 264 recruiting, 157 terminated. 446 Phase 2, 419 Phase 3, 300 Phase 1, 276 Not applicable, 137 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2446Completed 198, Recruiting 66, Unknown 62, Terminated 61, Active not recruiting 21, Not yet recruiting 20, Withdrawn 17, Enrolling by invitation 1
Phase 3419Completed 261, Recruiting 41, Unknown 32, Terminated 31, Active not recruiting 27, Withdrawn 18, Not yet recruiting 9
Phase 1300Completed 174, Recruiting 46, Terminated 35, Active not recruiting 13, Unknown 12, Not yet recruiting 11, Withdrawn 7, Enrolling by invitation 2
Not applicable276Completed 136, Unknown 53, Recruiting 27, Not yet recruiting 24, Terminated 19, Withdrawn 7, Active not recruiting 5, Enrolling by invitation 4, Suspended 1
Phase 4137Completed 78, Unknown 21, Recruiting 13, Terminated 10, Withdrawn 10, Active not recruiting 3, Not yet recruiting 2
Early Phase 119Completed 6, Recruiting 6, Unknown 4, Not yet recruiting 1, Terminated 1, Withdrawn 1

Follow Blood Coagulation Disorders: new trials by email Literature Review of Blood Coagulation Disorders trials Research Report on Blood Coagulation Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lentiviral FIX Gene Therapy
YUVA-GT-F901 - Hemophilia B
Phase 1Not yet recruitingShenzhen Geno-Immune Medical Institute102027-06-012026-11-02
Lentiviral FVIII Gene Therapy
YUVA-GT-F801 - Hemophilia A
Phase 1Not yet recruitingShenzhen Geno-Immune Medical Institute102027-06-012026-10-30
Post Approval Phase 4 Study to Learn More About How Safe Octocog Alfa is, and How Well it Works in Patients With Severe Hemophilia A in India
Octocog alfa - Severe Hemophilia A
Not yet recruitingBayer302027-04-052026-10-21
Multicomponent Pain Self-Management in Adults With Haemophilic Arthropathy
Multicomponent pain self-management programme - Hemophilic Arthropathy, Chronic Pain
Not applicableNot yet recruitingInvestigación en Hemofilia y Fisioterapia702027-03-012026-10-06
A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.
Ianalumab, Eltrombopag - Primary Immune Thrombocytopenia (ITP)
Phase 2Not yet recruitingNovartis Pharmaceuticals362027-02-082026-06-25
Ultrasound Assessment of Joint Health in Patients With Mild Hemophilia (Factor Levels 5-40%)
Joint Ultrasound (HEAD-US), Blood Sample for Coagulation Factor Measurement - Mild Hemophilia
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris1502027-02-012026-08-17
Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias
RXIM002 - Immune Thrombocytopenia (ITP)
Phase 1Not yet recruitingRiboX Therapeutics Ltd.272027-02-012026-10-28
WELL-MPN: A Digital Lifestyle App for Patients With MPNs
WELL-MPN Digital App - Myeloproliferative Neoplasms (MPNs)
Not applicableNot yet recruitingBrigham and Women's Hospital752027-01-012026-09-29
Efanesoctocog Prophylaxis Or The Optimization Of Treatment: Real-World Experience Of Taylorizing Clotting Therapy In Hemophilia A
Study questionnaires, Clinical/pharmacological data collection - Hemophilia A Patient
Not yet recruitingNantes University Hospital5532027-01-012026-09-25
Safety of Intraosseous Anaesthesia in Children With Haemophilia
Intraosseous Anaesthesia - Haemophilia A, Haemophilia B
Not applicableNot yet recruitingAnkara Yildirim Beyazıt University202027-01-012026-11-04
An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1
CAR-T cells targeting CD19 - Pemphigus Vulgaris (PV), ANCA Associated Vasculitis (AAV)
Phase 1 / Phase 2Not yet recruitingUniversity Hospital Tuebingen362027-01-012026-11-12
Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A
FRSW107 - Severe Hemophilia A
Phase 3Not yet recruitingHangzhou Gensciences Biopharmaceutical Co., Ltd.762026-12-252024-06-20
CD19-B Cell Depletion in PAIS-ME/CFS Patients
Inebilizumab, Placebo - Post-acute Infectious Syndrome (PAIS), Post-COVID 19 Condition (PCC or Long COVID)
Phase 2Not yet recruitingCharite University, Berlin, Germany382026-12-012026-07-24
A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA
Velinotamig specified dose on specified days. - Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (WAIHA)
Phase 1 / Phase 2Not yet recruitingCullinan Therapeutics Inc.722026-12-012026-07-31
Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia
Zanubrutinib 80mg/d, High dose dexamethasone, Zanubrutinib 160mg/d - Immune Thrombocytopenia
Phase 2Not yet recruitingPeking University People's Hospital902026-12-012026-11-12
Clinical Trial of NXT007 for the Prophylactic Treatment of Hemophilia A in Infants and Children
NXT007 - Hemophilia A
Phase 3RecruitingHoffmann-La Roche502026-11-302026-11-13
Liver Biopsy Following Gene Therapy For Hemophilia
Liver Biopsy - Hemophilia A, Hemophilia B
Not yet recruitingSt. Jude Children's Research Hospital82026-11-012026-10-22
Safflower (Carthamus Tinctorius L.) Granules for Sepsis-associated Coagulopathy
High-dose safflower granules, Medium-dose safflower granules, Placebo granules (one-tenth of medium-dose safflower) - Sepsis, Disseminated Intravascular Coagulation (DIC)
Not applicableNot yet recruitingShanghai Jiao Tong University School of Medicine2102026-11-012026-10-27
A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia
Sutacimig - Thrombasthenia
Phase 3RecruitingHemab ApS762026-10-272026-11-13
Study of Thyroid Dysfunction in Immune Thrombocytopenic Purpura Patients
Laboratory tests TSH, FT3, FT4 ,anti thyroglobulin antibodies, Anti -TPO antibodies - Thyroid Dysfunction, Immune Thrombocytopenic Purpura
Not yet recruitingSohag University502026-10-252026-10-28

Showing 20 of 2148. Sign in to see all of them.

Narrower conditions

Hemophilia A (790)  ·  Purpura, Thrombocytopenic, Idiopathic (483)  ·  Hemophilia B (262)  ·  Thrombocythemia, Essential (229)  ·  Polycythemia Vera (176)  ·  Primary Myelofibrosis (174)  ·  Myeloproliferative Disorders (145)  ·  von Willebrand Diseases (95)  ·  Leukemia, Myeloid, Acute (89)  ·  Leukemia, Myelomonocytic, Chronic (85)  ·  Myelodysplastic Syndromes (82)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (82)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (79)  ·  Multiple Myeloma (77)

Broader conditions

Hemic and Lymphatic Diseases (2147)  ·  Hematologic Diseases (2077)  ·  Hemorrhagic Disorders (1878)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1208)  ·  Genetic Diseases, Inborn (1127)  ·  Blood Coagulation Disorders, Inherited (1107)  ·  Coagulation Protein Disorders (1020)  ·  Pathological Conditions, Signs and Symptoms (960)  ·  Pathologic Processes (920)  ·  Blood Platelet Disorders (896)  ·  Signs and Symptoms (696)  ·  Immune System Diseases (679)  ·  Hemorrhage (656)  ·  Skin Manifestations (631)

Interventions

Factor VIII (137)  ·  eltrombopag (64)  ·  F8 protein, human (57)  ·  Rituximab (52)  ·  Dexamethasone (49)  ·  romiplostim (36)  ·  Factor IX (34)  ·  emicizumab (34)  ·  Cyclophosphamide (33)  ·  Blood Specimen Collection (31)  ·  fludarabine phosphate (30)  ·  Peripheral Blood Stem Cell Transplantation (26)  ·  BAY 14-2222 (23)  ·  Busulfan (21)  ·  Cyclosporine (21)

Sponsors

Novo Nordisk A/S (84)  ·  Baxalta now part of Shire (63)  ·  Bayer (62)  ·  Peking University People's Hospital (50)  ·  Institute of Hematology & Blood Diseases Hospital, China (49)  ·  Pfizer (47)  ·  CSL Behring (44)  ·  Shandong University (39)  ·  Octapharma (29)  ·  Takeda (27)  ·  Assistance Publique - Hôpitaux de Paris (25)  ·  Assiut University (23)  ·  Novartis Pharmaceuticals (23)  ·  Hoffmann-La Roche (21)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (21)

Countries

United States (776)  ·  France (348)  ·  China (319)  ·  United Kingdom (313)  ·  Italy (297)  ·  Spain (288)  ·  Germany (286)  ·  Canada (193)  ·  Turkey (Türkiye) (155)  ·  Japan (148)  ·  Poland (147)  ·  Australia (133)  ·  Netherlands (132)  ·  Austria (128)  ·  Belgium (104)

Top investigators

Lei Zhang, MD (26)  ·  Xiao-Hui Zhang, MD (14)

Results publications

PMID 40750723, PMID 19005182, PMID 26196195, PMID 36853224, PMID 40386832, PMID 42698050, PMID 19216617, PMID 19671919, PMID 24802773, PMID 35939785, PMID 36408876, PMID 19846889, PMID 25495795, PMID 26231455, PMID 26688484, PMID 26931631, PMID 31697801, PMID 33719084, PMID 33995988, PMID 34922648, PMID 35075289, PMID 36848635, PMID 39091324, PMID 12944568, PMID 17077333, PMID 17687129, PMID 17880439, PMID 18242413, PMID 20546023, PMID 21533818, PMID 22117897, PMID 22149959, PMID 22212248, PMID 22409309, PMID 22494019, PMID 22760174, PMID 22765835, PMID 23293082, PMID 23470153, PMID 23492914, PMID 24254965, PMID 24335249, PMID 24802775, PMID 25273984, PMID 25856035, PMID 26157075, PMID 26480931, PMID 26679394, PMID 27002680, PMID 27734464

NIH funding

2023 (31), 2016 (21), 2009 (20), 2018 (19), 2017 (16), 2015 (14), 2019 (14), 2014 (13), 2008 (12), 2025 (8), P01CA108671 (6), P30CA015083 (6), 2004 (4), 2005 (4), P30CA006973 (4)